1. Home
  2. BYSI vs ICCM Comparison

BYSI vs ICCM Comparison

Compare BYSI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYSI
  • ICCM
  • Stock Information
  • Founded
  • BYSI 2010
  • ICCM 2006
  • Country
  • BYSI United States
  • ICCM Israel
  • Employees
  • BYSI N/A
  • ICCM N/A
  • Industry
  • BYSI Biotechnology: Pharmaceutical Preparations
  • ICCM
  • Sector
  • BYSI Health Care
  • ICCM
  • Exchange
  • BYSI Nasdaq
  • ICCM Nasdaq
  • Market Cap
  • BYSI 73.4M
  • ICCM 61.1M
  • IPO Year
  • BYSI 2017
  • ICCM N/A
  • Fundamental
  • Price
  • BYSI $1.72
  • ICCM $1.04
  • Analyst Decision
  • BYSI
  • ICCM Strong Buy
  • Analyst Count
  • BYSI 0
  • ICCM 1
  • Target Price
  • BYSI N/A
  • ICCM $2.00
  • AVG Volume (30 Days)
  • BYSI 22.5K
  • ICCM 2.2M
  • Earning Date
  • BYSI 11-11-2025
  • ICCM 08-13-2025
  • Dividend Yield
  • BYSI N/A
  • ICCM N/A
  • EPS Growth
  • BYSI N/A
  • ICCM N/A
  • EPS
  • BYSI N/A
  • ICCM N/A
  • Revenue
  • BYSI N/A
  • ICCM $2,787,000.00
  • Revenue This Year
  • BYSI N/A
  • ICCM $3.95
  • Revenue Next Year
  • BYSI N/A
  • ICCM $266.15
  • P/E Ratio
  • BYSI N/A
  • ICCM N/A
  • Revenue Growth
  • BYSI N/A
  • ICCM N/A
  • 52 Week Low
  • BYSI $0.98
  • ICCM $0.48
  • 52 Week High
  • BYSI $3.44
  • ICCM $1.66
  • Technical
  • Relative Strength Index (RSI)
  • BYSI 38.49
  • ICCM 53.90
  • Support Level
  • BYSI $1.77
  • ICCM $1.01
  • Resistance Level
  • BYSI $1.93
  • ICCM $1.11
  • Average True Range (ATR)
  • BYSI 0.12
  • ICCM 0.06
  • MACD
  • BYSI 0.00
  • ICCM -0.00
  • Stochastic Oscillator
  • BYSI 15.15
  • ICCM 30.00

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: